[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![AponiaAnalytics Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1816152863069925376.png) aponia_analytics [@AponiaAnalytics](/creator/twitter/AponiaAnalytics) on x 4976 followers
Created: 2025-07-20 21:26:34 UTC

🦉 In the SELECT trial, weekly semaglutide reduced non-fatal MI in patients with ASCVD but no diabetes. In contrast, trials like EXSCEL and ELIXA showed no MI reduction in broader T2DM populations.

#GLP1 #diabetes $NVO $LLY $AZN $SNY $VKTX $GSK $PFE

![](https://pbs.twimg.com/card_img/1946688593658814466/Me5IeSTc?format=jpg&name=800x419)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947045490840797599/c:line.svg)

**Related Topics**
[pfe](/topic/pfe)
[sny](/topic/sny)
[manat](/topic/manat)
[$gsk](/topic/$gsk)
[$sny](/topic/$sny)
[$lly](/topic/$lly)
[mi](/topic/mi)
[$nvo](/topic/$nvo)

[Post Link](https://x.com/AponiaAnalytics/status/1947045490840797599)